UB Paderborn / Katalog / Suche / in CDI

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients

Kidney international, 2019-04, Vol.95 (4), p.983-991

2019

Link zum Volltext

Verfügbarkeit prüfen

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice

Circulation (New York, N.Y.), 2005-08, Vol.112 (7), p.1016-1023

2005

Link zum Volltext

Verfügbarkeit prüfen

Advanced glycation end products and mortality in hemodialysis patients

Kidney international, 2002-07, Vol.62 (1), p.301-310

2002

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein: A Family of Proteins to Regulate Cardiovascular Function

American journal of kidney diseases, 2006-02, Vol.47 (2), p.212-222

2006

Link zum Volltext

Verfügbarkeit prüfen

Monomeric C-Reactive Protein Decreases Acetylated LDL Uptake in Human Endothelial Cells

Clinical chemistry (Baltimore, Md.), 2009-09, Vol.55 (9), p.1728-1731

2009

Link zum Volltext

Verfügbarkeit prüfen

Tubular staining of modified C-reactive protein in diabetic chronic kidney disease

Nephrology, dialysis, transplantation, 2003-11, Vol.18 (11), p.2300-2307

2003

Link zum Volltext

Verfügbarkeit prüfen

Native C-reactive protein induces endothelial dysfunction in ApoE−/− mice: Implications for iNOS and reactive oxygen species

Atherosclerosis, 2007-12, Vol.195 (2), p.e76-e84

2007

Link zum Volltext

Verfügbarkeit prüfen

Should we reconsider the advanced glycation end product issue in hemodialysis patients?

American journal of kidney diseases, 2006-05, Vol.47 (5), p.923-923

2006

Link zum Volltext

Verfügbarkeit prüfen

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD

Journal of the American Society of Nephrology, 2021-05, Vol.32 (5), p.1174-1186

2021

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and cardiovascular risk in dialysis patients

Kidney international, 2002-05, Vol.61 (S80), p.S99-S102

2002

Link zum Volltext

Verfügbarkeit prüfen

The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study

The American journal of clinical nutrition, 2022-12, Vol.116 (6), p.1842-1851

2022

Link zum Volltext

Verfügbarkeit prüfen

Symptom Burden before and after Dialysis Initiation in Older Patients

Clinical journal of the American Society of Nephrology, 2022-12, Vol.17 (12), p.1719-1729

2022

Link zum Volltext

Verfügbarkeit prüfen

Chronic hypokalaemia and nephrocalcinosis

Clinical kidney journal, 2009-08, Vol.2 (4), p.314-317

2009

Link zum Volltext

Verfügbarkeit prüfen

Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up

American journal of kidney diseases, 2023-09, Vol.82 (3), p.257-266.e1

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD

Nephrology, dialysis, transplantation, 2023-10, Vol.38 (11), p.2494-2502

2023

Link zum Volltext

Verfügbarkeit prüfen

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

Journal of the American Heart Association, 2019-11, Vol.8 (21), p.e013091-e013091

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease

Clinical kidney journal, 2023-12, Vol.16 (12), p.2396-2404

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of spironolactone on diastolic function in haemodialysis patients

The International Journal of Cardiovascular Imaging, 2021-06, Vol.37 (6), p.1927-1936

2021

Link zum Volltext

Verfügbarkeit prüfen

The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease

Clinical kidney journal, 2022-04, Vol.15 (4), p.798-807

2022

Link zum Volltext

Verfügbarkeit prüfen

Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study

Clinical kidney journal, 2022-04, Vol.15 (4), p.786-797

2022

Link zum Volltext

Verfügbarkeit prüfen

Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study

Nephrology, dialysis, transplantation, 2019-07, Vol.34 (7), p.1189-1196

2019

Link zum Volltext

Verfügbarkeit prüfen

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients

Kidney international reports, 2022-10, Vol.7 (10), p.2230-2241

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Kidney international, 2001-02, Vol.59 (S78), p.S32-S36

2001

Link zum Volltext

Verfügbarkeit prüfen

Methods and implementation of a central biosample and data management in a three-centre clinical study

Computer methods and programs in biomedicine, 2008-07, Vol.91 (1), p.82-90

2008

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Kidney international, 2001-02, Vol.59 (s78), p.32-36

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice

Advanced glycation end products and mortality in hemodialysis patients

C-Reactive Protein: A Family of Proteins to Regulate Cardiovascular Function

Monomeric C-Reactive Protein Decreases Acetylated LDL Uptake in Human Endothelial Cells

Tubular staining of modified C-reactive protein in diabetic chronic kidney disease

Native C-reactive protein induces endothelial dysfunction in ApoE−/− mice: Implications for iNOS and reactive oxygen species

Should we reconsider the advanced glycation end product issue in hemodialysis patients?

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD

Inflammation and cardiovascular risk in dialysis patients

The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study

Symptom Burden before and after Dialysis Initiation in Older Patients

Chronic hypokalaemia and nephrocalcinosis

Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up

Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease

The effect of spironolactone on diastolic function in haemodialysis patients

The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease

Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study

Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Methods and implementation of a central biosample and data management in a three-centre clinical study

Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?

Suchergebnisse filtern